Furthermore, gene-environment interactions play a crucial role, where genetic polymorphisms in detoxification genes, notably N-acetyltransferase 2 (NAT2) and Glutathione S-transferase Mu 1 (GSTM1) increases the risk of BC [65]. Here, NAT2 is linked to breast cancer.